UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis

Nadir Abbas; Emma Culver; Douglas Thorburn; Neil Halliday; Hannah Crothers; Jessica Dyson; April Phaw; Richard Aspinall; Salim I. Khakoo; Yiannis Kallis; Belinda Smith; Imran Patanwala; Anne McCune; Chenchu Chimakurthi; Vinod S. Hegade; Michael Orrell; Rebecca Jones; George Mells; Colette Thain; Robert-Mitchell Thain; David Jones; Gideon M. Hirschfield; Palak Trivedi

doi:10.1016/j.cgh.2022.07.038

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Across the population of patients with primary biliary cholangitis in the United Kingdom, rates of biochemical response and drug discontinuation appear similar under fibric acid and OCA treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Abbas et al. (2022) studied this question.

synapsesocial.com/papers/69dd479e7808b00a4799c09a https://doi.org/10.1016/j.cgh.2022.07.038

View Full Paper

Ask AI

Bookmark

Share

UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis

Ask about this paper

Abstract

Discussion

Cite This Study

UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading